The title of this article should make everyone cringe. It is borrowed from an even more cringeworthy title of an article by David Feshbach that recently appeared in Barron’s financial magazine… “Autism Can Be a Growth Market, if Investors Help Scale It Up.” Clearly, there is an expectation that the autism epidemic of the past 30-plus years will continue to grow and, consequently, so will the opportunities for businesses that provide treatments (mostly drugs) for those affected by this neurological disorder. Read more.